Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

2.75p
   
  • Change Today:
      0.38p
  • 52 Week High: 4.25
  • 52 Week Low: 2.38
  • Currency: UK Pounds
  • Shares Issued: 356.04m
  • Volume: 2,632,112
  • Market Cap: 9.79m
2015-12-23 - Suspension of Listing

1 Day Chart (15-12-2017)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

HEMO Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
28-Feb-15 n/a (0.01) (0.40)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a 0.08 0.60p 6.3 n/a n/a n/a 0.0%
31-Dec-16 n/a (0.52) 0.80p 4.7 0.1 +34% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

HEMO Company Announcements

Result of AGM 07-Dec-2017 12:16 RNS
AGM Statement 07-Dec-2017 07:00 RNS
University of Oxford Collaboration 20-Nov-2017 07:00 RNS

Latest HEMO Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

HEMO Market Data

Currency UK Pounds
Share Price 2.75p
Change Today 0.38p
% Change 15.79 %
52 Week High 4.25
52 Week Low 2.38
Volume 2,632,112
Shares Issued 356.04m
Market Cap 9.79m

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Value Not Available
Income Not Available
Growth
17.66% above the market average17.66% above the market average17.66% above the market average17.66% above the market average17.66% above the market average
31.82% above the sector average31.82% above the sector average31.82% above the sector average31.82% above the sector average31.82% above the sector average

HEMO Dividends

No dividends found

Trades for 15-Dec-2017

Time Volume / Share Price
16:38 10,000 @ 2.95p
15:59 100,000 @ 2.83p
15:49 11,870 @ 2.85p
15:48 45,017 @ 2.89p
15:47 100,000 @ 2.56p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.
Chair Robin Campbell
Finance Director Timothy le Druillenec

Top of Page